PE20121029A1 - Marcadores de riesgo para enfermedad cardiovascular - Google Patents
Marcadores de riesgo para enfermedad cardiovascularInfo
- Publication number
- PE20121029A1 PE20121029A1 PE2011002069A PE2011002069A PE20121029A1 PE 20121029 A1 PE20121029 A1 PE 20121029A1 PE 2011002069 A PE2011002069 A PE 2011002069A PE 2011002069 A PE2011002069 A PE 2011002069A PE 20121029 A1 PE20121029 A1 PE 20121029A1
- Authority
- PE
- Peru
- Prior art keywords
- seq
- subject
- cardiovascular disease
- sample
- destined
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
REFERIDA A UN PROCEDIMIENTO PARA DETERMINAR SI UN SUJETO PRESENTA UN RIESGO AUMENTADO DE PADECER UNA ENFERMEDAD O TRASTORNO CARDIOVASCULAR ADVERSO O PARA DETERMINAR LA RESPUESTA FRENTE A UNA TERAPIA CARDIOVASCULAR EN UN SUJETO QUE COMPRENDE LAS ETAPAS DE DTERMINAR, EN UNA MUESTRA AISLADA DE DICHO SUJETO, LA PRESENCIA DE POLIMORFISMOS EN LAS POSICIONES 27 DENTREO DE LAS SECUENCIAS ACIDOS NUCLEICOS DE LA SEC ID NO:1 A 11, EN EL QUE LA PRESENCIA DE UNA C EN LA POSICION 27 EN LA SEC ID NO: 1, DE A EN LA SEC ID NO:2, DE C EN LA SEC ID NO:3, DE T EN LA SEC ID NO:4, DE C EN LA SEC ID NO:5, DE A EN LA SEC ID NO:6, DE T EN LA SEC ID NO:7, DE C EN LA SEC ID NO:8, DE C EN LA SEC ID NO:9, DE T EN LA SEC ID NO:9, DE T EN LA SEC ID NO:10 Y DE T EN LA SEC ID NO:11 ES INDICATIVA DE UN RIESGO AUMENTADO DE PADECER UNA ENFERMEDAD CARDIOVASCULAR SELECCIONADA DE INFARTO DE MIOCARDIO, ANGINA DE PECHO, ATAQUES ISQUEMICOS, INSUFICIENCIA CARDIACA CONGESTIVA, ANEURISMA AORTICO, ENTRE OTROS O UNA COMBINACION DE LOS MISMOS. DICHA MUESTRA ES UN TEJIDO O MUESTRA DE TEJIDO ORAL, RASPADO O LAVADO O UNA MUESTRA BIOLOGICA, DE PREFERENCIA SALIVA, ORINA O SANGRE
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09162329.8A EP2264183B1 (en) | 2009-06-09 | 2009-06-09 | Risk markers for cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20121029A1 true PE20121029A1 (es) | 2012-08-09 |
Family
ID=41061079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2011002069A PE20121029A1 (es) | 2009-06-09 | 2010-06-09 | Marcadores de riesgo para enfermedad cardiovascular |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9957565B2 (es) |
| EP (2) | EP2264183B1 (es) |
| AR (1) | AR077026A1 (es) |
| AU (1) | AU2010257482B2 (es) |
| BR (1) | BRPI1013082A2 (es) |
| CA (1) | CA2764693C (es) |
| CL (1) | CL2011003129A1 (es) |
| ES (2) | ES2623633T3 (es) |
| MX (1) | MX2011013243A (es) |
| PE (1) | PE20121029A1 (es) |
| PT (2) | PT2264183T (es) |
| RU (1) | RU2524659C2 (es) |
| UY (1) | UY32698A (es) |
| WO (1) | WO2010142713A1 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CA2801110C (en) | 2010-07-09 | 2021-10-05 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CN106198980B (zh) | 2010-08-13 | 2018-09-07 | 私募蛋白质体公司 | 胰腺癌生物标记及其用途 |
| US12077823B2 (en) | 2011-08-05 | 2024-09-03 | Genincode Plc | Risk assessment for cardiovascular disease |
| ES2573648T3 (es) * | 2011-08-05 | 2016-06-09 | Gendiag.Exe, S.L. | Marcadores genéticos para la evaluación del riesgo de enfermedad cardiovascular |
| JP6652781B2 (ja) * | 2011-09-30 | 2020-02-26 | ソマロジック・インコーポレーテッド | 心血管系リスクイベントの予測およびその使用 |
| EP2843056B8 (en) * | 2013-08-30 | 2019-06-26 | GENINCODE UK, Ltd. | Risk markers for cardiovascular disease in patients with chronic kidney disease |
| RU2547575C1 (ru) * | 2014-02-06 | 2015-04-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ прогнозирования течения хронической сердечной недостаточности |
| RU2602451C1 (ru) * | 2015-08-28 | 2016-11-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого" Министерства здравоохранения Российской Федерации | Способ диагностики генетической предрасположенности к развитию ишемического инсульта у больных с фибрилляцией предсердий |
| EP3360067B1 (en) * | 2015-10-07 | 2025-10-01 | The Board of Trustees of the Leland Stanford Junior University | Techniques for determining whether an individual is included in ensemble genomic data |
| RU2624859C1 (ru) * | 2016-06-15 | 2017-07-07 | Общество с ограниченной ответственностью "Меднорд-Техника" (ООО "Меднорд-Техника") | Способ оценки повышенного риска возникновения флеботромбозов у пациентов с ишемической болезнью сердца |
| CN106250524A (zh) * | 2016-08-04 | 2016-12-21 | 浪潮软件集团有限公司 | 一种基于语义信息的机构名抽取方法和装置 |
| US10451544B2 (en) | 2016-10-11 | 2019-10-22 | Genotox Laboratories | Methods of characterizing a urine sample |
| WO2019191010A1 (en) * | 2018-03-27 | 2019-10-03 | Aardvark Therapeutics Inc. | Personalized treatment method for congestive heart failure |
| US11308325B2 (en) * | 2018-10-16 | 2022-04-19 | Duke University | Systems and methods for predicting real-time behavioral risks using everyday images |
| CN110229882A (zh) * | 2019-07-03 | 2019-09-13 | 贵州省临床检验中心 | 一种与心血管疾病相关的mthfr基因分子标记及其应用 |
| CN110229881A (zh) * | 2019-07-03 | 2019-09-13 | 贵州省临床检验中心 | 一种与成人心血管疾病相关的snp分子标记及其应用 |
| CN112210598A (zh) * | 2019-07-11 | 2021-01-12 | 合肥中科普瑞昇生物医药科技有限公司 | 检测高血糖药物代谢相关基因多态性的引物组和试剂盒及它们的应用 |
| CN110607360A (zh) * | 2019-09-19 | 2019-12-24 | 华中科技大学同济医学院附属同济医院 | 一种评估慢性心力衰竭预后的引物组、试剂盒及评估慢性心力衰竭预后的方法 |
| JP7707157B2 (ja) * | 2019-09-25 | 2025-07-14 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | 遺伝性疾患を引き起こす変異を検出するためのキット |
| WO2021207587A1 (en) * | 2020-04-11 | 2021-10-14 | Geneticure Inc. | Genetic method for diagnosis and treatment of pre and post coronavirus infections |
| US11574738B2 (en) | 2020-04-30 | 2023-02-07 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
| US11967430B2 (en) | 2020-04-30 | 2024-04-23 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
| US11482302B2 (en) | 2020-04-30 | 2022-10-25 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
| US11610645B2 (en) * | 2020-04-30 | 2023-03-21 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
| US11978532B2 (en) | 2020-04-30 | 2024-05-07 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US723961A (en) | 1902-10-01 | 1903-03-31 | Nelson W Clark | Lady's belt, collar, or the like. |
| US4883750A (en) | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US5004565A (en) | 1986-07-17 | 1991-04-02 | The Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
| US5856522A (en) | 1995-05-04 | 1999-01-05 | Tropix, Inc. | Method of using synthesis of 1,2-dioxetanes and kits therefore |
| US5994073A (en) | 1990-08-30 | 1999-11-30 | Tropix, Inc. | Enhancement of chemiluminescent assays |
| WO1995011995A1 (en) | 1993-10-26 | 1995-05-04 | Affymax Technologies N.V. | Arrays of nucleic acid probes on biological chips |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
| US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| US5773628A (en) | 1994-11-14 | 1998-06-30 | Tropix, Inc. | 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use |
| US5591591A (en) | 1995-02-09 | 1997-01-07 | Tropix, Inc. | Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore |
| US5589136A (en) | 1995-06-20 | 1996-12-31 | Regents Of The University Of California | Silicon-based sleeve devices for chemical reactions |
| US5679803A (en) | 1995-10-25 | 1997-10-21 | Tropix, Inc. | 1,2 chemiluminescent dioxetanes of improved performance |
| US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
| US5800999A (en) | 1996-12-16 | 1998-09-01 | Tropix, Inc. | Dioxetane-precursor-labeled probes and detection assays employing the same |
| AU727083B2 (en) | 1997-04-25 | 2000-11-30 | Caliper Life Sciences, Inc. | Microfluidic devices incorporating improved channel geometries |
| US6159693A (en) | 1998-03-13 | 2000-12-12 | Promega Corporation | Nucleic acid detection |
| WO2002072889A2 (en) | 2001-01-12 | 2002-09-19 | Applera Corporation | Methods and compositions for microarray control |
| US20070015170A1 (en) * | 2005-07-12 | 2007-01-18 | Oy Jurilab Ltd | Method and kit for detecting a risk of coronary heart disease |
| RU2322193C1 (ru) | 2006-12-04 | 2008-04-20 | Федеральное государственное учреждение "Учебно-научный медицинский центр" Управления делами Президента Российской Федерации | Способ оценки генетического риска сердечно-сосудистых заболеваний у спортсменов |
| EA022610B1 (ru) * | 2007-02-21 | 2016-02-29 | Декоуд Дженетикс Ехф | Способ определения предрасположенности к сердечно-сосудистым заболеваниям с применением полиморфных маркеров |
| US7883851B2 (en) * | 2007-05-02 | 2011-02-08 | Board Of Regents, The University Of Texas System | Common allele on chromosome 9 associated with coronary heart disease |
-
2009
- 2009-06-09 PT PT91623298T patent/PT2264183T/pt unknown
- 2009-06-09 ES ES09162329.8T patent/ES2623633T3/es active Active
- 2009-06-09 EP EP09162329.8A patent/EP2264183B1/en not_active Not-in-force
-
2010
- 2010-06-09 AR ARP100102016A patent/AR077026A1/es unknown
- 2010-06-09 CA CA2764693A patent/CA2764693C/en active Active
- 2010-06-09 ES ES10725412.0T patent/ES2627446T3/es active Active
- 2010-06-09 RU RU2011154171/15A patent/RU2524659C2/ru not_active IP Right Cessation
- 2010-06-09 BR BRPI1013082A patent/BRPI1013082A2/pt not_active IP Right Cessation
- 2010-06-09 AU AU2010257482A patent/AU2010257482B2/en not_active Ceased
- 2010-06-09 US US13/377,216 patent/US9957565B2/en active Active
- 2010-06-09 PT PT107254120T patent/PT2440674T/pt unknown
- 2010-06-09 PE PE2011002069A patent/PE20121029A1/es not_active Application Discontinuation
- 2010-06-09 WO PCT/EP2010/058064 patent/WO2010142713A1/en not_active Ceased
- 2010-06-09 EP EP10725412.0A patent/EP2440674B1/en not_active Not-in-force
- 2010-06-09 UY UY0001032698A patent/UY32698A/es unknown
- 2010-06-09 MX MX2011013243A patent/MX2011013243A/es active IP Right Grant
-
2011
- 2011-12-09 CL CL2011003129A patent/CL2011003129A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9957565B2 (en) | 2018-05-01 |
| PT2264183T (pt) | 2017-03-14 |
| CA2764693C (en) | 2017-07-11 |
| EP2440674A1 (en) | 2012-04-18 |
| WO2010142713A1 (en) | 2010-12-16 |
| AU2010257482A1 (en) | 2012-02-02 |
| ES2627446T3 (es) | 2017-07-28 |
| UY32698A (es) | 2010-11-30 |
| EP2264183B1 (en) | 2016-12-07 |
| US20120141450A1 (en) | 2012-06-07 |
| RU2524659C2 (ru) | 2014-07-27 |
| AR077026A1 (es) | 2011-07-27 |
| MX2011013243A (es) | 2012-04-10 |
| ES2623633T3 (es) | 2017-07-11 |
| PT2440674T (pt) | 2017-05-23 |
| CA2764693A1 (en) | 2010-12-16 |
| EP2264183A1 (en) | 2010-12-22 |
| AU2010257482B2 (en) | 2014-01-23 |
| BRPI1013082A2 (pt) | 2016-07-26 |
| CL2011003129A1 (es) | 2012-04-27 |
| EP2440674B1 (en) | 2017-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20121029A1 (es) | Marcadores de riesgo para enfermedad cardiovascular | |
| Ghosheh et al. | Electro-metabolic coupling in multi-chambered vascularized human cardiac organoids | |
| CN104379740B (zh) | 新型fgfr3融合体 | |
| MX2010010465A (es) | Metodo para la deteccion de igf1r/chr 15 en celulas tumorales circulantes mediante hibridacion fluorescente in situ. | |
| Nollen et al. | What is new in the Marfan syndrome? | |
| NO20092530L (no) | Genetiske markorer for risikohandtering av hjertearrytmi | |
| EA200970781A1 (ru) | Варианты генетической предрасположенности, связанные с сердечно-сосудистыми заболеваниями | |
| JP7079937B2 (ja) | 肺血管疾患を治療するための組成物および方法 | |
| CY1116178T1 (el) | Αναστολεις των lox και loxl2 και χρησεις εξ' αυτων | |
| EP1933756A4 (en) | STEERING LESION-EXCLUSIVE HEART IMPLANTS IN CONGESTIVE HEART FAILURE | |
| AR088294A1 (es) | Determinacion de polimorfismos de un nucleotido simple utiles para predecir la respuesta clinica al acetato de glatiramero | |
| PL3689346T3 (pl) | 3,6-Dipodstawione sole ksantyliowe do leczenia tauopatii | |
| Medioni et al. | Expression of Slit and Robo genes in the developing mouse heart | |
| AU2010202926B2 (en) | Markers and methods relating to the assessment of Alzheimer's disease | |
| JP2015521475A5 (es) | ||
| ATE437965T1 (de) | Doppelsträngige sonden zur fluoreszenzdetektion von nukleinsäuren | |
| JP2018500884A5 (es) | ||
| Baggett et al. | Myofibroblast senescence promotes arrhythmogenic remodeling in the aged infarcted rabbit heart | |
| DE602006012995D1 (de) | Brustkrebsdiagnoseverfahren | |
| WO2011015348A3 (en) | Responsiveness to angiogenesis inhibitors | |
| FR2930036B1 (fr) | Procede de diagnostic d'une hypertension arterielle pulmonaire. | |
| Kals et al. | Optical tweezers reveal that PfEBA and PfRH ligands, not PfMSP1, play a central role in Plasmodium-falciparum merozoite-erythrocyte attachment | |
| AU2018297171B2 (en) | Compositions and methods for treating or preventing catecholaminergic polymorphic ventricular tachycardia | |
| Patzak et al. | Constriction velocities of renal afferent and efferent arterioles of mice are not related to SMB expression | |
| ATE497960T1 (de) | A1-adenosinrezeptoragonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |